Acknowledgement
- PDF / 143,003 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 33 Downloads / 161 Views
ACKNOWLEDGEMENT TO REFEREES
Acknowledgement Ó Springer International Publishing Switzerland 2013
Dear Reader As we reach the final issue of Sports Medicine for 2013, we hope that you have found the articles published throughout the year to be interesting and informative. The editor and publishing staff have appreciated the high quality of content contributed to the journal this year. The publishing schedule for 2014 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year. The quality of articles published in Sports Medicine was acknowledged in the new Impact Factor for 2012, which increased 1.6 % over that for 2011 to 5.237. The Adis portfolio as a whole saw impressive Impact Factor gains, with other flagship journals continuing to increase their citations—Drugs raised its Impact Factor to 4.633, with Clinical Pharmacokinetics also seeing a significant rise to 6.109. Pharmacoeconomics remains the number one journal in its field, and The Patient: Patient-Centered Outcomes Research saw an increase of more than 170 % in its Impact Factor to 1.565, only one year after first appearing in the Journal Citation ReportsÒ. 2013 saw the successful integration of the Adis portfolio of journals into the Springer production systems and custombuilt platforms (SpringerLink, Springer for R&D, and Springer for Hospitals & Health). We are confident that our authors and subscribers benefit from improved discoverability, mobile optimization and robust delivery of content on these platforms. Springer production capacity has also allowed us to increase the number of articles published while considerably reducing submission-to-publication times. Looking ahead to 2014, the Adis portfolio will continue to increase the amount of content published while maintaining high standards. The number of Adis titles will also increase as existing quality Springer journals are brought under the Adis brand—Advances in Therapy, Targeted Oncology, and the European Journal of Drug Metabolism and Pharmacokinetics. Adis is also committed to fostering Open Access publication: all Adis titles offer the Springer Open Choice option and we are adding a further ten fully Open Access titles in specific therapy areas such as Diabetes Therapy, Cardiology and Therapy and Dermatology and Therapy, previously published under the Springer Healthcare imprint. Information about the portfolio can be found on Springer.com/Adis. We would like to thank all the authors who have contributed articles to Sports Medicine over the last 12 months. They have generously set aside time in their busy schedules to prepare content, and without their hard work and diligence we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals
Data Loading...
